Form 4 for HCSG HEALTHCARE SERVICES GROUP INC
Accepted 2026-01-06 00:00:00 ET · period of report 2025-12-31 · accession 0001454244-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-06 | 2026-01-03+ | HCSG | WAHL Theodore | Pres, CEO, Dir | M - OptEx | $0.00 | +84.8K | 494.5K | +21% | $0 |
| D | 2026-01-06 | 2025-12-31 | HCSG | WAHL Theodore | Pres, CEO, Dir | A - Grant | $9.88 | +2,145 | 437.5K | +0.5% | +$21.2K |
| D | 2026-01-06 | 2026-01-04 | HCSG | WAHL Theodore | Pres, CEO, Dir | F - Tax | $0.00 | -35.5K | 486.9K | -7% | $0 |
| DM | 2026-01-06 | 2026-01-03+ | HCSG | WAHL Theodore | Pres, CEO, Dir | M - OptEx | $0.00 | -84.8K | 91.9K | -48% | $0 |
| DM | 2026-01-06 | 2025-12-31+ | HCSG | WAHL Theodore | Pres, CEO, Dir | A - Grant | $0.5525 | +96.5K | 41.2K | New | +$53.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-04 | M | A | 16,292 | $0.00 | 463,828 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-03 | M | A | 27,842 | $0.00 | 522,313 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-04 | M | A | 10,024 | $0.00 | 447,536 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-31 | A | A | 2,145 | $9.88 | 437,512 | D | — | — | (F1) Acquired by the Reporting Person through participation in the Healthcare Services Group, Inc. Employee Stock Purchase Plan. |
| 5 | Common | Common Stock | 2026-01-04 | F | D | 35,450 | $0.00 | 486,863 | D | — | — | (F2) Total direct and indirect beneficial ownership by reporting person is 604,211. |
| 6 | Common | Common Stock | 2026-01-03 | M | A | 30,643 | $0.00 | 494,471 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2026-01-03 | M | D | 27,842 | $0.00 | 111,366 | D | — · — to — | 27,842 Common Stock | (F3) Shares issued at the conversion rate of 1-for-1. (F9) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2025 grant date. |
| 8 | Derivative | Restricted Stock Units | 2026-01-05 | A | A | 93,693 | $0.00 | 93,693 | D | — · — to — | 93,693 Common Stock | (F3) Shares issued at the conversion rate of 1-for-1. (F10) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 5, 2026 grant date. |
| 9 | Derivative | Phantom Stock | 2025-12-31 | A | A | 2,788 | $19.12 | 41,171 | D | — · — to — | 2,788 Common Stock | (F4) Shares of Phantom Stock are payable in-kind following termination of the Reporting Person's employment with Issuer. (F5) Acquired pursuant to an Issuer contribution under the Healthcare Services Group, Inc. Deferred Compensation Plan. (F3) Shares issued at the conversion rate of 1-for-1. |
| 10 | Derivative | Restricted Stock Units | 2026-01-04 | M | D | 16,292 | $0.00 | 16,291 | D | — · — to — | 16,292 Common Stock | (F3) Shares issued at the conversion rate of 1-for-1. (F7) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2022 grant date. |
| 11 | Derivative | Restricted Stock Units | 2026-01-04 | M | D | 10,024 | $0.00 | 0 | D | — · — to — | 10,024 Common Stock | (F3) Shares issued at the conversion rate of 1-for-1. (F6) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2021 grant date. |
| 12 | Derivative | Restricted Stock Units | 2026-01-03 | M | D | 30,643 | $0.00 | 91,927 | D | — · — to — | 30,643 Common Stock | (F3) Shares issued at the conversion rate of 1-for-1. (F8) These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2024 grant date. |